Veracyte, Inc. (VCYT)
NASDAQ: VCYT · Real-Time Price · USD
49.22
+1.42 (2.97%)
Jun 3, 2026, 3:45 PM EDT - Market open
Veracyte Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | - | 362.58 | 239.09 | 216.45 | 154.25 | 173.2 |
Short-Term Investments | 175.92 | 50.31 | 50.35 | - | 24.61 | 3.96 |
Cash & Short-Term Investments | 175.92 | 412.89 | 289.44 | 216.45 | 178.85 | 177.16 |
Cash Growth | -38.78% | 42.65% | 33.72% | 21.02% | 0.95% | -49.29% |
Accounts Receivable | 50.11 | 44.66 | 46.53 | 40.38 | 44.02 | 41.46 |
Inventory | 21.42 | 20.55 | 21.75 | 16.13 | 14.29 | 11.23 |
Other Current Assets | - | 10.28 | 14.55 | 12.66 | 11.47 | 13.26 |
Total Current Assets | 247.45 | 488.38 | 372.27 | 285.62 | 248.64 | 243.1 |
Net Property, Plant & Equipment | 58.52 | 58.79 | 71.14 | 30.86 | 30.86 | 31.14 |
Other Intangible Assets | 85.86 | 89.15 | 102.3 | 88.59 | 174.87 | 202.73 |
Goodwill | 767.15 | 767.15 | 745.8 | 702.98 | 695.89 | 707.9 |
Other Long-Term Assets | 2.69 | 2.55 | 8.53 | 6.85 | 6.17 | 2.95 |
Total Assets | 1,436 | 1,406 | 1,300 | 1,115 | 1,156 | 1,188 |
Accounts Payable | 6.91 | 4.59 | 8.63 | 12.94 | 11.91 | 12.36 |
Accrued Expenses | 43.13 | 48.8 | 43.83 | 38.43 | 37.77 | 39.48 |
Current Portion of Long-Term Debt | - | - | - | - | - | 1.13 |
Current Portion of Leases | 4.35 | 4.05 | 7.5 | 5.11 | 4.07 | 3.63 |
Unearned Revenue | 0.75 | 1.16 | 1.67 | 2.01 | 2.61 | 4.65 |
Other Current Liabilities | 0.98 | 1.33 | 17 | 2.76 | 6.25 | 2.91 |
Total Current Liabilities | 56.12 | 59.94 | 78.63 | 61.24 | 62.61 | 64.15 |
Long-Term Leases | 34.99 | 35.6 | 43.24 | 7.53 | 10.65 | 14.1 |
Other Long-Term Liabilities | 0.89 | 0.9 | 2.2 | 2.04 | 7.96 | 13.06 |
Total Long-Term Liabilities | 35.88 | 36.51 | 45.44 | 9.56 | 18.61 | 27.16 |
Total Liabilities | 91.99 | 96.44 | 124.07 | 70.8 | 81.22 | 91.31 |
Common Stock | - | 0.08 | 0.08 | 0.07 | 0.07 | 0.07 |
Additional Paid-in Capital | 1,701 | 1,695 | 1,656 | 1,536 | 1,500 | 1,469 |
Accumulated Other Comprehensive Income | -8.22 | -8.21 | -36.09 | -24.02 | -31.35 | -15.08 |
Retained Earnings | -348.92 | -377.63 | -443.98 | -468.12 | -393.72 | -357.16 |
Shareholders' Equity | 1,344 | 1,310 | 1,176 | 1,044 | 1,075 | 1,097 |
Total Liabilities & Equity | 1,436 | 1,406 | 1,300 | 1,115 | 1,156 | 1,188 |
Total Debt | 39.33 | 39.65 | 50.74 | 12.63 | 14.72 | 18.85 |
Net Cash (Debt) | 136.59 | 373.24 | 238.7 | 203.82 | 164.13 | 158.31 |
Net Cash Growth | -63.40% | 56.36% | 17.11% | 24.18% | 3.68% | -53.03% |
Net Cash Per Share | 1.70 | 4.63 | 3.05 | 2.81 | 2.29 | 2.33 |
Book Value | 1,344 | 1,310 | 1,176 | 1,044 | 1,075 | 1,097 |
Book Value Per Share | 16.76 | 16.25 | 15.04 | 14.37 | 15.03 | 16.15 |
Tangible Book Value | 491.31 | 453.27 | 327.87 | 252.53 | 204.44 | 185.88 |
Tangible Book Value Per Share | 6.13 | 5.63 | 4.19 | 3.48 | 2.86 | 2.74 |